Literature DB >> 4929936

Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.

F Panettiere, C A Coltman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4929936     DOI： 10.1002/1097-0142(197104)27:4<835::aid-cncr2820270413>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  14 in total

1.  Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.

Authors:  P De Besi; B Busnardo; S Toso; M E Girelli; D Nacamulli; N Simioni; D Casara; P Zorat; M V Fiorentino
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

2.  (-)-Emetine and macromolecular biosynthesis in Ehrlich ascites-tumour cells.

Authors:  R K Johnson; W R Jondorf
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

3.  Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines.

Authors:  Emmanuel S Akinboye; Zebalda D Bamji; Bernard Kwabi-Addo; David Ejeh; Robert L Copeland; Samuel R Denmeade; Oladapo Bakare
Journal:  Bioorg Med Chem       Date:  2015-07-04       Impact factor: 3.641

4.  Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment.

Authors:  Christian K Hirt; Tijmen H Booij; Linda Grob; Patrik Simmler; Nora C Toussaint; David Keller; Doreen Taube; Vanessa Ludwig; Alexander Goryachkin; Chantal Pauli; Daniela Lenggenhager; Daniel J Stekhoven; Christian U Stirnimann; Katharina Endhardt; Femke Ringnalda; Lukas Villiger; Alexander Siebenhüner; Sofia Karkampouna; Marta De Menna; Janette Beshay; Hagen Klett; Marianna Kruithof-de Julio; Julia Schüler; Gerald Schwank
Journal:  Cell Genom       Date:  2022-02

5.  Emetine regulates the alternative splicing of caspase 9 in tumor cells.

Authors:  Danmin Pan; Kritsanapol Boon-Unge; Piyarat Govitrapong; Jianhua Zhou
Journal:  Oncol Lett       Date:  2011-08-29       Impact factor: 2.967

6.  Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.

Authors:  Kritsanapol Boon-Unge; Qingming Yu; Tie Zou; An Zhou; Piyarat Govitrapong; Jianhua Zhou
Journal:  Chem Biol       Date:  2007-12

7.  Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancer.

Authors:  Emmanuel S Akinboye; Marc D Rosen; Samuel R Denmeade; Bernard Kwabi-Addo; Oladapo Bakare
Journal:  J Med Chem       Date:  2012-08-16       Impact factor: 7.446

8.  Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus.

Authors:  Rupkatha Mukhopadhyay; Sujayita Roy; Rajkumar Venkatadri; Yu-Pin Su; Wenjuan Ye; Elena Barnaeva; Lesley Mathews Griner; Noel Southall; Xin Hu; Amy Q Wang; Xin Xu; Andrés E Dulcey; Juan J Marugan; Marc Ferrer; Ravit Arav-Boger
Journal:  PLoS Pathog       Date:  2016-06-23       Impact factor: 6.823

9.  Recent developments on potential new applications of emetine as anti-cancer agent.

Authors:  Philip F Uzor
Journal:  EXCLI J       Date:  2016-05-10       Impact factor: 4.068

10.  Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axis.

Authors:  Vivian P Wagner; Marco A T Martins; Manoela D Martins; Kristy A Warner; Liana P Webber; Cristiane H Squarize; Jacques E Nör; Rogerio M Castilho
Journal:  Oncotarget       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.